Canopy Growth Corporation

TSX:WEED.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$0.72 +2.26%

+$0.03 today

Market cap
$323.72M
Beta
2.41
P/E (TTM)
-1.8
EPS (TTM)
-$0.76
52W Low $1.18High $3.28

Volume 1.16M

Average 2.07M

WEED.TO Capital Expenditures

Cash spent on property, plant, equipment, and other long-term assets.

Canopy Growth CorporationTSX: WEED.TO

Capital Expenditures · Q4 FY2025 · quarter ended Mar 2026

Capital expenditures declines year over year

Q4 FY2025 capital expenditures of CA$1.11M (cash outflow) fell 64.8% year over year, behind the -42.9% change in trailing-twelve-month capital expenditures. Sequentially, it fell 38.4% from the prior quarter. Over 3 fiscal years it compounded at -17.4% a year.

Context

  • Capital expenditures amounted to 2.1% of revenue in FY2025, down 2.1 pp from a year earlier.
  • Capital expenditures grew in size in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from -64.8% toward the trailing-twelve-month pace of -42.9%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-CA$1.11M-38.4% QoQ
Last fiscal yearMar 2026
-CA$5.95M-47.2% YoY
LTMMar 2026
-CA$6.44M-42.9% YoY
Capital Expenditures past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-64.8%——
1 year-47.2%——
3-year CAGR-17.4%——
5-year CAGR——
10-year CAGR——

Capital Expenditures history

CAD · from the cash flow

Latest · FY2025
(5.95M) CAD
Year-over-year change
+47.2%

Capital Expenditures vs competitors

How WEED.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so capital expenditures is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -42.9% is the lowest of 7, against a peer median of +24.4%.
  • Capital expenditures amounts to 2.1% of revenue for WEED.TO, versus a peer median of 2.1%.
WEED.TO Competitors
Capital Expenditures for WEED.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ACB.TOAurora Cannabis Inc.LTM Mar 2026CA$22.55M CAD+19.5%+22.9%7.1%
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026CA$11.19M CAD+1.5%—4.1%
TSND.TOTerrAscend Corp.LTM Mar 2026$6.87M USD-37.4%-45.7%2.6%
WEED.TOCanopy Growth CorporationLTM Mar 2026CA$6.44M CAD-42.9%-17.4%2.1%
XLY.TOAuxly Cannabis Group Inc.LTM Mar 2026CA$3.26M CAD+29.2%-35.1%2.1%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 2026$107.42K USD+168.5%-29.4%0.2%
EDT.TOSpectral Medical Inc.LTM Mar 2026CA$28K CAD+154.5%+80.8%1.0%
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026$3.64 USD——0.0%
Peer median (excluding WEED.TO) —+24.4%-29.4%2.1%

Competitors are the stored peer set for WEED.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

CAD
Metric
FY2021
Mar 2022
FY2022
Mar 2023
FY2023
Mar 2024
FY2024
Mar 2025
FY2025
Mar 2026
Net Income(320.49M)(723.36M)(483.68M)(604.14M)(262.91M)
Depreciation & Amortization114.42M80.03M53.18M43.12M36.47M
Deferred Income Tax(8.95M)(5.73M)12.33M7.14M23K
Stock-Based Compensation46.69M25.32M14.18M(4.21M)4.27M
Change in Working Capital165.56M65.85M(38.69M)(41.36M)27.38M
Accounts Receivables13.6M(9.91M)(3.75M)(4.49M)25.69M
Inventory173.19M55.64M1.03M(17.72M)3.71M
Accounts Payables(35.84M)17.63M9.12M(15.48M)(4.35M)
Other Working Capital14.61M2.48M(45.09M)(3.68M)2.34M
Other Non-Cash Items(543.88M)339K160.74M433.7M130.96M
Operating Cash Flow(545.81M)(557.55M)(281.95M)(165.75M)(63.81M)
Capital Expenditures(48.11M)(10.55M)(4M)(11.28M)(5.95M)
Acquisitions (Net)103.2M(9.29M)(955K)(6.97M)(41.54M)
Purchases of Investments(379.41M)(67.15M)(347K)(95.34M)0
Sales of Investments545.99M502.59M78.55M16.43M19M
Other Investing Activities9.15M17.79M167.38M48.9M6.52M
Investing Cash Flow230.82M433.38M241.59M(47.79M)(21.35M)
Debt Repayment(50.76M)16.98M(509.78M)(220.78M)(13.52M)
Common Stock Issued2.7M1.05M81.06M385.39M374.17M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities2.53M(37.72M)(36.34M)(15.96M)(28.24M)
Financing Cash Flow(45.53M)(19.69M)(465.06M)148.66M332.41M
Effect of Forex Changes(18.12M)44.86M(1.29M)8.39M3.62M
Net Change in Cash(378.65M)(99M)(506.71M)(56.49M)250.87M
Free Cash Flow(593.92M)(568.1M)(285.95M)(177.03M)(69.76M)

Canopy Growth Corporation

TSX:WEED.TO

Intrinsic Alpha fair value

Locked

Current Price

$0.72

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.